Ellingson Rachel
Known title: SVP & Chief Strategy OfficerCIK: 0001557271
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Zimmer Biomet Extends Exclusive Distribution Deal with Think Surgical. Zimmer Biomet has extended its exclusive distribution agreement with Think Surgical to supply the wireless TMINI miniature robotic system. The deal expands the company's reach in surgical robotics and aligns with its strategy of partnering with innovative technology providers. It follows strong Q2 results that benchmarked well against peers in the surgical equipment sector, reinforcing Zimmer Biomet’s competitive position within the S&P 500.
Transaction History
| BLFS | ▼ Sell | Other | 57,995 | — | 10/6/2026 | View on chart |
| BLFS | ▲ Buy | Grant | 8,170 | — | 2/24/2026 | View on chart |
| BLFS | ▲ Buy | Grant | 6,876 | — | 3/18/2025 | View on chart |
| ZBH | ▲ Buy | Option Exercise | 1,566 | $0 | 2/20/2025 | View on chart |
| ZBH | ▼ Sell | Tax Withholding | 491 | $51K | 2/20/2025 | View on chart |
| ZBH | ▼ Sell | Tax Withholding | 1,792 | $181K | 2/18/2025 | View on chart |
| ZBH | ▲ Buy | Option Exercise | 5,572 | $0 | 2/18/2025 | View on chart |
| BLFS | ▲ Buy | Grant | 11,264 | — | 3/8/2024 | View on chart |
| ZBH | ▲ Buy | Option Exercise | 1,419 | $0 | 3/6/2024 | View on chart |
| ZBH | ▼ Sell | Tax Withholding | 445 | $56K | 3/6/2024 | View on chart |
| ZBH | ▲ Buy | Option Exercise | 1,762 | $0 | 2/25/2024 | View on chart |
| ZBH | ▼ Sell | Tax Withholding | 588 | $76K | 2/25/2024 | View on chart |
| BLFS | ▲ Buy | Grant | 495 | — | 11/1/2023 | View on chart |
| BLFS | ▲ Buy | Grant | 362 | — | 10/1/2023 | View on chart |
| ZBH | ▼ Sell | Tax Withholding | 361 | $45K | 2/21/2023 | View on chart |
| ZBH | ▲ Buy | Option Exercise | 1,046 | $0 | 2/21/2023 | View on chart |
| BLFS | ▲ Buy | Grant | 10,187 | — | 1/3/2023 | View on chart |
| BLFS | ▲ Buy | Grant | 259 | — | 8/1/2022 | View on chart |
| BLFS | ▲ Buy | Grant | 341 | — | 7/1/2022 | View on chart |
| BLFS | ▲ Buy | Grant | 311 | — | 6/1/2022 | View on chart |
| BLFS | ▲ Buy | Grant | 14,730 | — | 5/6/2022 | View on chart |
| ZBH | ▲ Buy | Option Exercise | 531 | $0 | 5/1/2022 | View on chart |
| ZBH | ▼ Sell | Tax Withholding | 167 | $20K | 5/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Analyst Pieces Highlight BioLife Solutions' Customer Retention, Momentum
Two analyst pieces this week focused on BioLife Solutions. Diamond Hill pointed to the company's high switching costs, suggesting customers face barriers to moving to competitors, which can support steady revenue. ChartMill separately noted the stock shows strong growth momentum along with a potential breakout setup. The stock is trading near the lower end of its 52-week range, while analysts maintain an average price target around $31, well above current levels.
Analyst Pieces Highlight BioLife Solutions' Customer Retention, Momentum. Two analyst pieces this week focused on BioLife Solutions. Diamond Hill pointed to the company's high switching costs, suggesting customers face barriers to moving to competitors, which can support steady revenue. ChartMill separately noted the stock shows strong growth momentum along with a potential breakout setup. The stock is trading near the lower end of its 52-week range, while analysts maintain an average price target around $31, well above current levels.